Lectenz® Bio News – Page 2 of 5

January 25, 2021 0 0

Lectenz Bio has recently signed a distribution agreement with 2B Scientific, a life sciences distributor. This agreement will allow 2B Scientific...

December 7, 2020 0 0

Lectenz Bio has recently signed a distribution agreement with Funakoshi Co., Ltd., a Japanese life science distributor. This agreement will allow...

March 16, 2020 0 0

We’d like to take a brief moment to update you on our company plans as the COVID-19 situation progresses. At Lectenz Bio, our employees’ safety is...

January 23, 2020 0 0

The NIH National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase I to develop heparan sulfate...

January 10, 2020 0 0

The NIH National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase I to develop fucose...

September 4, 2019 0 0

Lectenz Bio attended the ACS Fall 2019 National Meeting, where Dr. Matthew Saunders presented Glycosense™: Simple alternative to existing...

August 28, 2019 0 0

Lectenz Bio founders, Lori Yang and Rob Woods are highlighted in an ASBMB featured story, Setting Sail in a Startup: How academic entrepreneurs...

July 8, 2019 0 0

Christian Gerner-Smidt and Lori Yang attended the 20th European Carbohydrate Symposium in Leiden, The Netherlands. Dr. Yang gave a lecture...

July 1, 2019 0 0

Lectenz Bio completed the Spring 2019 SBIR NIH I-Corps cohort in Bethesda Maryland! During the 8-week program, our team – Sean Wu (C-Level...

June 28, 2019 0 0

Dr. Lori Yang and Dr. Joshua Renfroe presented posters at the 34th Congress of the International Society for Advancement of Cytometry in...

May 14, 2019 0 0

Dr. Sean Wu and Dr. Joshua Renfroe attend the 13th Jenner Glycobiology and Medicine Symposium in Cambridge, MA. Learn more about the Jenner...

April 29, 2019 0 0

Lectenz Bio has been accepted to the National Institute of Health (NIH) I-Corps program for SBIR phase I awardees. The goal of the program is to...